Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Cellular Physiology

• Publication date

  2016-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcp.25020PMID 25899717PMCID PMC4586905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

  2014influential reference
• Osteoactivin Induces Transdifferentiation of C2C12 Myoblasts Into Osteoblasts

  2014cited by this paper
• TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation

  2012cited by this paper
• Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice

  2012influential reference
• Different effects on bone strength and cell differentiation in pre pubertal caloric restriction versus hypothalamic suppression.

  2011cited by this paper
• Temporal and spatial expression of osteoactivin during fracture repair

  2010cited by this paper
• Functional roles of osteoactivin in normal and disease processes.

  2010cited by this paper
• Effects of core binding factor α1 or bone morphogenic protein‐2 overexpression on osteoblast/cementoblast‐related gene expressions in NIH3T3 mouse cells and dental follicle cells

  2009cited by this paper
• Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function.

  2008influential reference
• Age-Related Changes in Trabecular Architecture Differ in Female and Male C 57 BL / 6 J Mice *

  2007cited by this paper
• Osteoactivin acts as downstream mediator of BMP‐2 effects on osteoblast function

  2007influential reference
• Age‐Related Changes in Trabecular Architecture Differ in Female and Male C57BL/6J Mice

  2007cited by this paper
• Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo.

  2005cited by this paper
• Exogenous Runx2 Expression Enhances in Vitro Osteoblastic Differentiation and Mineralization in Primary Bone Marrow Stromal Cells

  2004cited by this paper
• Cbfa1/osf2 Transduced Bone Marrow Stromal Cells Facilitate Bone Formation In Vitro and In Vivo

  2004cited by this paper
• Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro.

  2003cited by this paper
• Identification and characterization of the genes encoding human and mouse osteoactivin.

  2003cited by this paper
• BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression*

  2003cited by this paper
• The molecular biology of distraction osteogenesis.

  2002cited by this paper
• High Bone Resorption in Adult Aging Transgenic Mice Overexpressing Cbfa1/Runx2 in Cells of the Osteoblastic Lineage

  2002cited by this paper
• Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts

  2001cited by this paper
• Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12

  2000cited by this paper
• Expression of growth factors in the mandibular distraction zone: a sheep study.

  1999cited by this paper
• Mechanical Tension‐Stress Induces Expression of Bone Morphogenetic Protein (BMP)‐2 and BMP‐4, but Not BMP‐6, BMP‐7, and GDF‐5 mRNA, During Distraction Osteogenesis

  1999cited by this paper
• Growth factors in distraction osteogenesis. Immuno-histological pattern of TGF-beta1 and IGF-I in human callus induced by distraction osteogenesis.

  1999cited by this paper
• Growth factors in distraction osteogenesis

  1999cited by this paper
• Cbfa1 Isoforms Exert Functional Differences in Osteoblast Differentiation*

  1999cited by this paper
• The role of transforming growth factor-beta, insulin-like growth factor I, and basic fibroblast growth factor in distraction osteogenesis of the mandible.

  1999cited by this paper
• Expression of Bone Matrix Proteins mRNA During Distraction Osteogenesis

  1998cited by this paper
• Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

  1997cited by this paper
• Growth factors for bone growth and repair: IGF, TGF beta and BMP.

  1996cited by this paper
• Growth factors for bone growth and repair: IGF, TGFβ and BMP

  1996cited by this paper
• TGF-beta 1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-beta 1.

  1993cited by this paper
• Transforming growth factor-β enhances fracture healing in rabbit tibiae

  1993cited by this paper
• Transforming growth factor-beta enhances fracture healing in rabbit tibiae.

  1993cited by this paper
• TGF‐β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF‐β1

  1993cited by this paper
• Identification and analysis of transforming growth factor beta receptors on primary osteoblast-enriched cultures derived from adult human bone.

  1992cited by this paper
• In vivo induction of bone by recombinant human transforming growth factor beta 1.

  1991cited by this paper
• Rapid publication TGF‐β1 induces bone closure of skull defects

  1991cited by this paper
• In vivo induction of bone by recombinant human transforming growth factor β1

  1991cited by this paper
• Rapid publication. TGF-beta 1 induces bone closure of skull defects.

  1991cited by this paper
• In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice

  1990cited by this paper
• Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae.

  1990cited by this paper
• Expression of human bone-related proteins in the hematopoietic microenvironment.

  1990cited by this paper
• In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice.

  1990cited by this paper
• Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae*

  1990cited by this paper
• In vivo stimulation of bone formation by transforming growth factor-beta.

  1989cited by this paper
• Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.

  1987cited by this paper
• Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro

  1987influential reference
• Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae.

  1986cited by this paper

• A Novel Bone Shield to Improve Skeletal Health during Space Exploration and for Disuse Conditions on Earth.

  2026cites this paper
• The glycoprotein GPNMB protects against oxidative stress through enhanced PI3K/AKT signaling in epidermal keratinocytes

  2025cites this paper
• Fabrication and Evaluation of Thermoresponsive GPNMB-Hydrogels as an Innovative Osteogenic Therapeutic Strategy

  2025cites this paper
• Proteins extracted from placenta regulate osteogenic differentiation of human mesenchymal stem cells.

  2025cites this paper
• The Anti-Inflammatory Role of GPNMB in Post-Traumatic Osteoarthritis

  2025cites this paper
• Genetic Profiling of MC3T3-E1 Cells in Different Media: Implications for In Vitro Screening Development

  2025cites this paper
• Harnessing Engineered Extracellular Vesicles from Mesenchymal Stem Cells as Therapeutic Scaffolds for Bone‐Related Diseases

  2024cites this paper
• Bone-marrow macrophage-derived GPNMB protein binds to orphan receptor GPR39 and plays a critical role in cardiac repair

  2024cites this paper
• The expression and function of Gpnmb in lymphatic endothelial cells.

  2024cites this paper
• The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling

  2024cites this paper
• Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes

  2024cites this paper
• Gpnmb silencing protects against hyperoxia-induced acute lung injury by inhibition of mitochondrial-mediated apoptosis

  2024cites this paper
• The Lymphatic Endothelial Cell Secretome Inhibits Osteoblast Differentiation and Bone Formation

  2023cites this paper
• Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I.

  2023cites this paper
• Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2

  2022influential citation
• A novel molecular mechanism of vascular fibrosis in Takayasu arteritis: macrophage-derived GPNMB promoting adventitial fibroblast extracellular matrix production in the aorta.

  2022cites this paper
• Novel Genetic Determinants of Dental Maturation in Children

  2022cites this paper
• GPNMB promotes abdominal fat deposition in chickens: genetic variation, expressional profile, biological function, and transcriptional regulation

  2022cites this paper
• A genetic correlation scan identifies blood proteins associated with bone mineral density

  2022cites this paper
• Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis

  2022cites this paper
• Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias

  2021cites this paper
• Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model.

  2021cites this paper
• Quantitative trait locus mapping identifies the Gpnmb gene as a modifier of mouse macrophage lysosome function

  2021cites this paper
• Landscape of microenvironment in Randall’s plaque by single-cell sequencing

  2021cites this paper
• Overexpressed osteoactivin reduced osteoclastic callus resorption during distraction osteogenesis in mice

  2020cites this paper
• The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33

  2020cites this paper
• Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases

  2020cites this paper
• Transgenic Overexpression of GPNMB Protects Against MPTP-Induced Neurodegeneration

  2020cites this paper
• Integrins and other cell surface attachment molecules of bone cells

  2020cites this paper
• Functional characterization of Gpnmb in inflammatory and metabolic diseases

  2020cites this paper
• Elevated circulating Gpnmb levels are associated with hyperthyroidism

  2020cites this paper
• The role of miR-150 regulates bone cell differentiation and function.

  2020cites this paper
• Cycloastragenol prevents age-related bone loss: Evidence in d-galactose-treated and aged rats.

  2020cites this paper
• The suppressive effects of miR-508-5p on the odontogenic differentiation of human dental pulp stem cells by targeting glycoprotein non-metastatic melanomal protein B

  2019cites this paper
• Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry

  2019cites this paper
• Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

  2019cites this paper
• 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin dose‐dependently increases bone mass and decreases marrow adiposity in juvenile mice

  2018cites this paper
• Prolonged high force high repetition pulling induces osteocyte apoptosis and trabecular bone loss in distal radius, while low force high repetition pulling induces bone anabolism.

  2018cites this paper
• Defining Inflammatory Cell States in Rheumatoid Arthritis Joint Synovial Tissues by Integrating Single-cell Transcriptomics and Mass Cytometry

  2018cites this paper
• Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.

  2018cites this paper
• Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease

  2017influential citation
• Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer☆

  2017cites this paper
• THE EPIGENETIC REGULATION OF OSTEOACTIVIN/GPNMB IN BONE CELLS

  2017influential citation
• CD11b promotes the differentiation of osteoclasts induced by RANKL through the spleen tyrosine kinase signalling pathway

  2017cites this paper
• Prospects of osteoactivin in tissue regeneration

  2016cites this paper
• Osteoactivin inhibition of osteoclastogenesis is mediated through CD44-ERK signaling

  2016cites this paper
• Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping

  2016cites this paper
• Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models

  2016cites this paper
• Cancer–Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer

  2015cites this paper